Home The Word Brain My Amedeo FAQ Privacy About   


C49 + CC Journal Club

For more information, please refer to our special emails from April 13 and May 19.

  Irritable Bowel Syndrome

  Free Subscription


14.04.2025

1 Afr Health Sci
1 Aliment Pharmacol Ther
1 BMC Gastroenterol
1 Br J Nutr
1 Digestion
1 Expert Opin Drug Saf
1 Front Public Health
1 Gut Liver
1 Inflamm Bowel Dis
1 J Glob Health
1 J Neurogastroenterol Motil
1 Microbiome Res Rep
1 Neuromodulation
1 United European Gastroenterol J


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Afr Health Sci

  1. WANG Q, Zhao L, Liu J, Chen L, et al
    Meta analysis of clinical efficacy of acupoint application in the treatment of irritable bowel syndrome.
    Afr Health Sci. 2024;24:351-361.
    PubMed         Abstract available


    Aliment Pharmacol Ther

  2. KHUNSRIRAKSAKUL C, Ziegler O, Liu D, Kulaylat AS, et al
    The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population-Based Study.
    Aliment Pharmacol Ther. 2025 Apr 11. doi: 10.1111/apt.70147.
    PubMed         Abstract available


    BMC Gastroenterol

  3. LUO J, To WLW, Xu Q, Zhang J, et al
    Clinical practice guidelines for the diagnosis of constipation-predominant irritable bowel syndrome and functional constipation in adults: a scoping review.
    BMC Gastroenterol. 2025;25:234.
    PubMed         Abstract available


    Br J Nutr

  4. JAFARI NASAB S, Feizi A, Hajihashemi P, Ani A, et al
    Dietary Quality Index-International and the odds of irritable bowel syndrome: a case-control study.
    Br J Nutr. 2025 Apr 10:1-26. doi: 10.1017/S0007114525000753.
    PubMed         Abstract available


    Digestion

  5. YAMANE T, Masaoka T, Ishii C, Masuoka H, et al
    Factors contributing to the efficacy of fecal microbiota transplantation for diarrhea-dominant functional bowel disorders.
    Digestion. 2025 Apr 10:1-22. doi: 10.1159/000545183.
    PubMed         Abstract available


    Expert Opin Drug Saf

  6. ANDREWS MB, Adler DG
    Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database.
    Expert Opin Drug Saf. 2025 Apr 9:1-7. doi: 10.1080/14740338.2025.2490841.
    PubMed         Abstract available


    Front Public Health

  7. ZHONG Y, Bai H, Zhang Y, Yang X, et al
    Association of rotating shift work with incident irritable bowel syndrome: a large population-based prospective cohort study.
    Front Public Health. 2025;13:1541122.
    PubMed         Abstract available


    Gut Liver

  8. XUE F, Xue J, Zhao B, Zhu S, et al
    The Associations of Tobacco, Alcohol, and Coffee Consumption with Upper and Lower Gastrointestinal Disease Risk: A Mendelian Randomization Study.
    Gut Liver. 2025 Apr 11. doi: 10.5009/gnl240440.
    PubMed         Abstract available


    Inflamm Bowel Dis

  9. MUJAGIC Z
    Gut Feelings Matter: The Unresolved Questions of Irritable Bowel Syndrome-Like Symptoms in Inflammatory Bowel Disease in Remission.
    Inflamm Bowel Dis. 2025 Apr 9:izaf066. doi: 10.1093.
    PubMed        


    J Glob Health

  10. CHU H, Zhong Y, Zhao J, Shan Y, et al
    Unravelling behavioural contributions to IBS risk: evidence from univariate and multivariate Mendelian randomisation.
    J Glob Health. 2025;15:04112.
    PubMed         Abstract available


    J Neurogastroenterol Motil

  11. CHOI Y, Youn YH, Kang SJ, Shin JE, et al
    2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2025;31:133-169.
    PubMed         Abstract available


    Microbiome Res Rep

  12. BOCCHIO F, Mancabelli L, Milani C, Lugli GA, et al
    Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases.
    Microbiome Res Rep. 2024;4:2.
    PubMed         Abstract available


    Neuromodulation

  13. SANTUCCI NR, Waheed U, Li J, Mansi S, et al
    Auricular Allodynia is Associated With Worse Outcomes in Children With Functional Abdominal Pain Disorders Using Neurostimulation.
    Neuromodulation. 2025 Apr 10:S1094-7159(25)00129.
    PubMed         Abstract available


    United European Gastroenterol J

  14. MELCHIOR C, Hreinsson JP, Tack J, Keller J, et al
    Disorders of the gut-brain interaction among European people with obesity: Prevalence and burden of compatible symptoms.
    United European Gastroenterol J. 2025 Apr 7. doi: 10.1002/ueg2.12700.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.